mitoxantrone

Poland

Drugs containing this active substance

  • MITOXANTRONE SANDOZ

    The medicine is used in the treatment of advanced breast cancer, non-Hodgkin lymphoma, acute myeloid leukemia, chronic myeloid leukemia (in blast crisis phase), pain associated with prostate cancer, and highly active relapsing multiple sclerosis.

    Form: solution for infusion, concentrate

    Active substance Dosage
    mitoxantrone 20 mg/10 ml

    ATC: L01DB07

    Manufacturer: Ebewe Pharma Ges.m.b.H Nfg. KG Fareva Unterach GmbH